KEVIN SNYDER: Open Payments
NPI 1174583959 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,092 in 51 payments from 13 companies in 2025. Trend: 2023 $1,065 · 2024 $872 · 2025 $1,092
Food & beverage: $1,092
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $388 |
| Novo Nordisk Inc | 7 | $194 |
| Orexo US, Inc. | 6 | $99 |
| Amgen Inc. | 4 | $68 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| Lilly USA, LLC | 3 | $55 |
| Indivior Inc. | 2 | $49 |
| Exact Sciences Corporation | 2 | $38 |
| PFIZER INC. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
Products named: QULIPTA, Ozempic, Zubsolv, SHINGRIX, Rybelsus, VRAYLAR, MOUNJARO, EVENITY.
Industry payments across MD — which companies pay providers there.
